Services we offer
Clinical sample analysis
Do you want to offer microbiome profiling to your patients? Our service laboratory performs the CE-IVD approved Dysbiosis Test and COVID-19 Fecal Test routinely. We provide the complete workflow, from sample collection solutions to analysis reporting. This service is for laboratories, clinics, and healthcare providers.
Research sample analysis
Do you wish to incorporate microbiome analysis in your research project? With our extensive clinical research expertise within the gut microbiome field, we will help you pick the right study design and bioinformatic analyses. Send us your samples and we will provide the complete workflow tailored to your needs!
Assay development
Our microbiome expertise expands to probe and primer design for custom GA-map® and PCR assay development. The GA-map® platform offers endless possibilities for multiplex microbiome assays, spanning from diagnostic to targeted research assays. The unmatched level of standardization makes GA-map® the benchmark microbiome platform.
Scientific advice
Missing experience in the microbiome field? We are happy to share our expertise in study design, microbiome analysis, bioinformatic analysis and scientific writing.
Do our services fit your profile? Contact us to talk about your needs or simply request a quote for your samples.
Clinical sample analysis
CE-IVD analysis
Validated parameters
Easy reporting
Short turnaround
Clinical sample analysis
Standardized and clinically validated testing of the gut microbiome to measure and characterize dysbiosis can be a helpful tool when choosing the right treatment regime and monitoring progress in your patients. Our service laboratory performs routine analyses of patient and fecal donor samples using our CE-IVD GA-map® Dysbiosis Test and GA-map® COVID-19 Fecal Test. Microbiome profiling and identification of dysbiosis is recommended in:
- Comprehensive diagnosis of gastrointestinal disorders
- Mapping and aiding gastrointestinal symptoms
- IBS and IBD symptom and treatment management
- Diet management
Your microbiome research partner
50+ publications
70+ clinical trials
Bioinformatic expertise
Standardized platform
End-to-end research service
An increasing number of researchers have discovered the efficiency and simplicity of GA-map® in microbiome analysis. We offer a unique, highly standardized platform, featuring an end-to-end workflow for targeted microbiome analysis. We provide services tailored for all types of clinical research.
GA-map® Dysbiosis Test is a CE-IVD approved microbiome test for detection and characterization of dysbiosis in human fecal samples, providing microbiome profiling with an intrinsic healthy reference.
GA-map® Discovery is a comprehensive set of microbiome markers for Research Use Only, providing deep insight into gut and oral bacteria, based on analysis of over 170 clinically important targets.
GA-map® COVID-19 Fecal Test is a CE-IVD test for detection of SARS-CoV-2 virus in human fecal samples.
The GA-map® Platform has until now been applied in clinical research in the fields of gastroenterology and metabolic disorders. Explorethe full publication list below.
Your research project timeline
Step 1: Study design consultancy
Our experienced team will help you decide the perfect study set up, sample collection solution, and choose the right analyses.
Step 2: Sample collection and shipment
We run microbiome analyses on fecal samples, saliva samples, or pre-extracted gDNA. We assist you with solutions for easy sample collection.
Step 3: Sample analysis
We run the study samples according to agreed protocol and timeline. We pride ourselves on the complete sample workflow and short turnaround.
Step 4: Data analysis
GA-map® results are easy to interpret and require no data storage capacity. Bioinformatic analysis is performed upon request.
We used GA-map® in our clinical research within IBS. We have great experience with GA-map® as a tool to select, monitor and follow-up patients.
Professor Magdy El-Salhy
Stord Hospital, Helse Bergen and the University of Bergen, Norway
There is still so much to learn about the microbiome, we are only just beginning to discover its importance, and the GA-map® Dysbiosis Test will help us do just that.
Emeritus Professor Peter Malfertheiner
Senior Professor at the Ludwig Maximillian University, University Clinic in Munich, Germany
Assays developed on the GA-map® platform
Standardized
High multiplex
Short turnaround
Easy to integrate
Assay development
The GA-map® platform holds the potential for development of In-Vitro Diagnostic (IVD) tests for all diseases and conditions involving microbiome. The low requirement of specialized laboratory equipment and the unmatched platform standardization give you an ideal starting point for easy IVD assay development. We are happy to merge our expertise in microbiome marker and primer design with your assay requests. Contact us to find out more about our assay development platform, or to discuss your ideas.